Coronavirus update: Stage 2 human clinical trials for Oxford vaccine begin
India reported 60,975 new cases of COVID-19 and 848 deaths in the last 24 hours
The curious case of Covaxin royalties
ICMR’s contradictions and obfuscation on ownership of the vaccine’s intellectual property is not helping in the fight against COVID-…
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
Drug Controller General dodges query on COVID-19 vaccine adverse event
Govt webinar on clinical trials also skips questions on emergency authorisation, expert committees
COVID-19 in Africa: The pain of getting the jab
The COVAX Facility and the African Union are struggling to bring some relief to Africa which has been suffering from vaccine apartheid
COVID-19 vaccine: WTO chief brushes aside TRIPS waiver
Ngozi Okonjo-Iweala offers ‘third way’ to bridge the COVID vaccine shortfall based on more licensing agreements
Coronavirus variants: why being more transmissible rather than more deadly isn’t good news
At the heart of this assertion lies an old foe that has plagued us right from the start of this pandemic: exponential growth
Govt neither denies nor accepts adverse event in Serum Institute COVID-19 vaccine trial
Health secretary claims all procedures followed but refuses to divulge details
India may conduct trial or bridging study on Russian COVID-19 vaccine: Govt
Would India also go EUA way on vaccine? Official says, too early to say anything
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
Coronavirus update: EU leaders reach landmark deal on COVID-19
Serum Institute of India to apply for local trials of Oxford University’s vaccine candidate in India within a week
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached